Growth Metrics

Palisade Bio (PALI) Non-Current Receivables (2016 - 2018)

Palisade Bio (PALI) has disclosed Non-Current Receivables for 3 consecutive years, with $298238.0 as the latest value for Q4 2018.

  • On a quarterly basis, Non-Current Receivables fell 18.39% to $298238.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $298238.0, a 18.39% decrease, with the full-year FY2018 number at $298238.0, down 18.39% from a year prior.
  • Non-Current Receivables was $298238.0 for Q4 2018 at Palisade Bio, up from $290354.0 in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $424240.0 in Q4 2016 to a low of $290354.0 in Q3 2018.
  • A 3-year average of $362131.7 and a median of $360815.0 in 2017 define the central range for Non-Current Receivables.
  • Peak YoY movement for Non-Current Receivables: fell 13.86% in 2017, then decreased 18.48% in 2018.
  • Palisade Bio's Non-Current Receivables stood at $424240.0 in 2016, then decreased by 13.86% to $365456.0 in 2017, then decreased by 18.39% to $298238.0 in 2018.
  • Per Business Quant, the three most recent readings for PALI's Non-Current Receivables are $298238.0 (Q4 2018), $290354.0 (Q3 2018), and $343281.0 (Q2 2018).